Scrip
GENova Biotherapeutics causes concern as media blitz culminates in stock trading suspension – update
05 October 2009
Eleanor Malone
Please Login to read the full article.
05 October 2009
Eleanor Malone
eleanor.malone@informa.com
The US SEC has suspended trading in the tiny biotech newcomer GENova Biotherapeutics after its share price rose more than 30-fold. GENova burst onto the scene in September with a flurry of press releases about agreements it is signing.
On September 23rd, the SEC announced it had halted...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US court urged to revamp inequitable conduct doctrine in patent litigation
- Regeneron's Arcalyst passes one gout trial, fails another
- US appeals court narrows securities fraud case against ex-BMS finance chief
- Europe's top universities threaten €2 billion pharma innovation project boycott
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
